Weight Loss Drugs Go DTC & the Santa Claus Rally Stumbles 01/04/24

Squawk Pod

CNBC

Business News, News, Investing, Business

4.2 • 543 Ratings

🗓️ 4 January 2024

⏱️ 34 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Eli Lilly will now sell weight loss drugs directly to consumers. In a big move, the drugmaker has announced LillyDirect, a platform that uses telehealth to improve consumer access to weight loss drugs like Lilly’s Mounjaro and its recently approved Zepbound. CNBC’s Bertha Coombs explains the impact LillyDirect will have on health care and on pharmacy benefit providers like those of CVS, UnitedHealth, and Cigna. Primary care physician Dr. Kavita Patel underscores the health care access problem that millions of Americans face, and whether Eli Lilly’s effort could alleviate some of those pressures. Plus, CNBC’s Jon Fortt sees Apple’s 2024 going two very different directions after 2023’s stock strength and sales weakness. Microsoft keyboards are ready for their biggest change in almost 30 years, and the market’s Santa Claus rally is officially behind us–maybe. Bertha Coombs - 14:05 Dr. Kavita Patel - 24:11 Jon Fortt - 31:22 In this episode: Dr. Kavita Patel, @kavitapmd Bertha Coombs, @berthacoombs Jon Fortt, @jonfortt Becky Quick, @BeckyQuick Michael Santoli, @michaelsantoli Steve Liesman, @steveliesman Katie Kramer, @Kramer_Katie

Transcript

Click on a timestamp to play from that location

0:00.0	Bring in show music please.
0:03.0	Hi, I'm C NBC producer Katie Kramer today on Squawk Pod.
0:08.0	Drugmaker Eli Lilly, the company behind weight loss meds like Manjaro and Zep Bound, will now sell its drugs
0:15.7	directly to consumers.
0:17.5	It's a shake up to pricing and to health care, says the NBC's Bertha Coombs.
0:21.8	That transparent pricing is really a shot across the
0:25.0	bow at the big three pharmacy benefit managers, Signas Express Crips, CVS's
0:30.8	care mark, and United Health's opt them.
0:33.6	Primary care physician Kavita Patel on the problems Lily could solve.
0:37.9	Every single phone call I get is my pharmacy is out of, fill in the blank,
0:42.4	and I think this is basically another mechanism to make sure that those calls don't have to happen.
0:47.0	And Apple had a tough year for sales but a banner year for its stock.
0:52.0	John Ford has all the possible outcomes for the Giants
0:55.1	2024.
0:56.1	I'm not saying it'll keep its 2.9 trillion dollar market cap.
1:00.0	I'm just saying that it's not the worst house on the mega cap blocks.
1:03.4	Plus the rest of today's headlines that got us squawking.
1:07.4	Microsoft's first changed since the 90s, the end of office space, and two Fed heads walk into a bar.
1:14.1	Oh, wait, wrong one.
1:15.5	You know the one of the stockbroker and the economist are walking along
1:18.2	to see the $20 bill on the floor?
1:21.0	It's Thursday January 4, 2024.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.